Rohit Bhatheja, MD, MBA, FACC, FSCAI

Rohit Bhatheja, MD, MBA, FACC, FSCAI

Medical Director, Cardiologist

Heart, Lung & Vascular

Rohit Bhatheja

Overview

Rohit Bhatheja, MD, MBA, FACC, FSCAI is an award-winning cardiologist with board certification in cardiovascular disease, interventional cardiology, and internal medicine. As a member of the esteemed AdventHealth Medical Group cardiology team and part of the AdventHealth Cardiovascular Institute, he consults with patients at his offices in Celebration and Orlando. A leading physician and clinical investigator, he has been honored with awards from the National Institutes of Health, the American College of Physicians, and the Cleveland Clinic Foundation. Dr. Bhatheja graduated from Maulana Azad Medical College in New Delhi, India, prior to undertaking his residency training at the Cleveland Clinic in Ohio. He received advanced training as an Interventional Fellow in cardiovascular medicine, peripheral vascular, structural heart, and carotid interventions at the University of Kentucky.

Articles

First-in-Human Study to Assess the Safety and Feasibility of the Bashir Endovascular Catheter for the Treatment of Acute Intermediate-Risk Pulmonary Embolism

CIRCULATION-CARDIOVASCULAR INTERVENTIONS

2021

Novel Micro Crown Orbital Atherectomy for Severe Lesion Calcification Coronary Orbital Atherectomy System Study (COAST)

CIRCULATION-CARDIOVASCULAR INTERVENTIONS

2020

A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism The SEATTLE II Study

JACC-CARDIOVASCULAR INTERVENTIONS

2015

Percutaneous Transcatheter Closure of the Aortic Valve

ANNALS OF THORACIC SURGERY

2015

Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)

JACC-CARDIOVASCULAR INTERVENTIONS

2014

Acute coronary syndromes: Unstable angina/non-ST elevation myocardial infarction

CRITICAL CARE CLINICS

2007

Heart rate response during Dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms

AMERICAN JOURNAL OF CARDIOLOGY

2005

More Publication Information

Education & Training

Education

Medical School: Maulana Azad Medical College, New Delhi, India
MBA - Kellogg School of Management - Northwestern University, Evanston IL

Residency

Cleveland Clinic Foundation

Fellowship

University of Kentucky Albert B. Chandler Hospital

Specialty

Cardiology

Board Certifications

Cardiovascular Diseases - American Board of Internal Medicine (ABIM) Interventional Cardiology - American Board of Internal Medicine (ABIM)

Associated Clinical Trials

NCT04508023

A multicenter, randomized, placebo-controlled, pragmatic Phase 3 study investigating the efficacy and safety of rivaroxaban to reduce the risk of major venous and arterial thrombotic events, hospitalization and death in medically ill outpatients with acute, symptomatic COVID-19 infection

Icon for trial | 39039039DVT3004 A multicenter, randomized, placebo-controlled, pragmatic Phase 3 study investigating the efficacy and safety of rivaroxaban to reduce the risk of major venous and arterial thrombotic events, hospitalization and death in medically ill outpa

The purpose of this study is to see if the study drug, rivaroxaban, is safe and useful for reducing the risk of blood clots in subjects who are diagnosed with COVID-19 and who have additional conditions that increase their risk ...